Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, randomized, double-blind, placebo-controlled, 30-week, adaptive cross-over study, with a Treatment Period of approximately 26 weeks under the Original Design or, if applicable, a 17-week parallel study, with a Treatment Period of approximately 14 weeks under the Contingent Design.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03496623
Study type Interventional
Source United Therapeutics
Contact Prakash Sista, Ph.D.
Phone 240-821-1661
Email 304perfectstudy@lungbiotechnology.com
Status Recruiting
Phase Phase 3
Start date June 27, 2018
Completion date September 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Recruiting NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT03449056 - High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease Phase 3
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Recruiting NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System. N/A
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Recruiting NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy N/A
Not yet recruiting NCT02748798 - Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders Early Phase 1
Not yet recruiting NCT03453606 - Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT02557178 - Home-Based Health Management of COPD Patients Phase 2
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Recruiting NCT02823795 - The Supporting Patient Activation in Transition to Home Intervention N/A
Recruiting NCT02690038 - Ig PRx in AECOPD: Pilot Study Phase 2
Enrolling by invitation NCT02999685 - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients N/A
Not yet recruiting NCT02892396 - Influence of Electronic Cigarettes in the Evaluation of the Inflammatory Response in Patients With a Diagnosis of COPD N/A
Recruiting NCT02563184 - Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease Phase 4
Completed NCT02519608 - ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts Phase 2
Completed NCT02750189 - The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea N/A